Fig. 6From: DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomyKaplan–Meier survival analyses for patients with different treatment strategies. Kaplan–Meier curves of DFS for patients in entire cohort (a), high-risk group defined by the radiomic signature (b), and the high-risk group defined by the radiomic nomogram (c). Kaplan–Meier curves of OS for patients in entire cohort (d), high-risk group defined by the radiomic signature (e), and defined by the radiomic nomogram (f)Back to article page